Proteases and cystic fibrosis.

Area of Science:

• Pulmonary Medicine
• Genetics
• Immunology

Background:

• Cystic fibrosis (CF) is a leading inherited fatal disease in Caucasians.
• Chronic lung disease, characterized by infection, inflammation, bronchiectasis, and respiratory failure, is the primary cause of morbidity and mortality in CF patients.
• Key pathological features include abnormal mucus, chronic infections (e.g., Staphylococcus aureus, Pseudomonas aeruginosa), and neutrophil-dominant airway inflammation.

Purpose of the Study:

• To review the mechanisms by which proteases impact airway function in cystic fibrosis.
• To highlight the role of elevated protease concentrations in the airway surface liquid (ASL) in exacerbating CF lung disease.
• To discuss the contribution of proteases, particularly neutrophil elastase, to CF pathology.

Main Methods:

• Literature review of existing research on cystic fibrosis lung disease.
• Analysis of the role of proteases in airway pathology.
• Examination of protease interactions with airway clearance and immune functions.

Main Results:

• Proteases, especially neutrophil elastase, are present at high concentrations in the ASL of CF patients.
• These proteases are unopposed and contribute significantly to CF lung disease pathology.
• Proteases impair mucociliary clearance, interfere with innate immune responses, and perpetuate neutrophilic inflammation.

Conclusions:

• Proteases play a critical role in the pathogenesis of cystic fibrosis lung disease.
• Understanding protease mechanisms is crucial for developing targeted therapies for CF.
• Targeting protease activity may offer a therapeutic strategy to mitigate lung damage in CF.